129 related articles for article (PubMed ID: 19520161)
1. Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione.
Takahashi M; Handa W; Umeta H; Ishikawa S; Yamashita K; Numazawa M
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):191-9. PubMed ID: 19520161
[TBL] [Abstract][Full Text] [Related]
2. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
Takahashi M; Yamashita K; Numazawa M
Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
[TBL] [Abstract][Full Text] [Related]
4. Studies directed towards a mechanistic evaluation of inactivation of aromatase by the suicide substrates androsta-1,4-diene-3,17-diones and its 6-ene derivatives aromatase inactivation by the 19-substituted derivatives and their enzymic aromatization.
Numazawa M; Nagaoka M; Handa W; Ogawa Y; Matsuoka S
J Steroid Biochem Mol Biol; 2007; 107(3-5):211-9. PubMed ID: 17656084
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors.
Numazawa M; Yamaguchi S
Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379
[TBL] [Abstract][Full Text] [Related]
6. 6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships.
Numazawa M; Oshibe M; Yamaguchi S
Steroids; 1997; 62(8-9):595-602. PubMed ID: 9292934
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biochemical properties of 6-bromoandrostenedione derivatives with a 2,2-dimethyl or 2-methyl group as aromatase inhibitors.
Numazawa M; Handa W; Yamada K
Biol Pharm Bull; 2004 Nov; 27(11):1878-82. PubMed ID: 15516742
[TBL] [Abstract][Full Text] [Related]
8. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
Numazawa M; Yoshimura A; Oshibe M
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors.
Numazawa M; Ando M; Watari Y; Tominaga T; Hayata Y; Yoshimura A
J Steroid Biochem Mol Biol; 2005 Jun; 96(1):51-8. PubMed ID: 16039845
[TBL] [Abstract][Full Text] [Related]
11. Biological aromatization of delta4,6- and delta1,4,6-androgens and their 6-alkyl analogs, potent inhibitors of aromatase.
Numazawa M; Yoshimura A
J Steroid Biochem Mol Biol; 1999; 70(4-6):189-96. PubMed ID: 10622407
[TBL] [Abstract][Full Text] [Related]
12. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
Numazawa M; Shelangouski M; Nagasaka M
Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions.
Numazawa M; Handa W; Hasegawa C; Takahashi M
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):353-9. PubMed ID: 16209922
[TBL] [Abstract][Full Text] [Related]
14. Studies on the catalytic function of aromatase: aromatization of 6-alkoxy-substituted androgens.
Numazawa M; Ando M; Zennyoji R
J Steroid Biochem Mol Biol; 2002 Sep; 82(1):65-73. PubMed ID: 12429140
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biochemical studies of 7 alpha-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
Ebrahimian S; Chen HH; Brueggemeier RW
Steroids; 1993 Sep; 58(9):414-22. PubMed ID: 8236327
[TBL] [Abstract][Full Text] [Related]
16. 7alpha-Arylaliphatic androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
O'Reilly JM; Brueggemeier RW
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):93-102. PubMed ID: 9009242
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
[TBL] [Abstract][Full Text] [Related]
18. [Development of aromatase inhibitors and analysis of their inhibitory activities].
Numazawa M
Yakugaku Zasshi; 1998 Dec; 118(12):539-53. PubMed ID: 9921263
[TBL] [Abstract][Full Text] [Related]
19. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
